Enanta Pharmaceuticals | ENTA - Рыночная капитализация

Биржевая цена
12.65
Изменение за день
0.14 1.12%
Ежемесячно
-14.24%
Ежегодный
104.03%
Q1 прогноз
12.13




Рыночная капитализация Изменить Дата
AbbVie USD 403.83B 5.2B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Anika Therapeutics USD 210M 71M 2026-03
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 133M 105M 2026-03
Incyte USD 19.39B 2.83B 2025-12
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 500.24B 67.44B 2025-12
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 240.48B 51.73B 2026-03
Novavax USD 1.43B 340M 2026-03
Pfizer USD 153.96B 12.4B 2026-03
PTC Therapeutics USD 6.1B 1.22B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12